Citation tools

Katsuno, Kenji et al "Sergliflozin, a Novel Selective Inhibitor of Low-Affinity Sodium Glucose Cotransporter (SGLT2), Validates the Critical Role of SGLT2 in Renal Glucose Reabsorption and Modulates Plasma Glucose Level." Journal of Pharmacology and Experimental Therapeutics 320.1 (2007): 323-330. Web. 23 Dec. 2024.